SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-19-021505
Filing Date
2019-11-26
Accepted
2019-11-26 16:08:34
Documents
10
Period of Report
2019-11-26
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm 8-K 22807
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 26875
3 EXHIBIT 99.2 ex99_2.htm EX-99.2 26177
4 EXHIBIT 99.3 ex99_3.htm EX-99.3 5946
5 EXHIBIT 99.4 ex99_4.htm EX-99.4 44988
6 EXHIBIT 99.5 ex99_5.htm EX-99.5 36435
7 image00001.jpg GRAPHIC 23875
8 image1.jpg GRAPHIC 44663
9 image00002.jpg GRAPHIC 68298
10 image00003.jpg GRAPHIC 22555
  Complete submission text file 0001140361-19-021505.txt   384304
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 191250918
SIC: 2834 Pharmaceutical Preparations